EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: SECONDARY-TYPE MUTATIONS IN ELN 2022 FAVORABLE RISK AML & RESULTS FROM THE HARMONY PLATFORM